CoverageForm 410-K10-Q8-K13D13G13F

VRAY · Viewray, Inc. - Financials

Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.

Income Statement

Line itemFY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Revenue$102.21M$70.12M$57.02M$87.78M$22.24M$34.04M
Cost of Revenue$92.16M$69.78M$61.08M$93.26M$25.87M$27.71M
Gross Profit$10.04M$335.0K($4.06M)($5.48M)$6.60M$6.33M
R&D$32.43M$31.85M$25.01M$23.79M$16.52M$14.71M
SG&A$52.44M$56.09M$61.73M$65.72M$50.11M$31.38M
Total Operating Expenses$117.17M$103.98M$101.92M$115.32M$81.69M$54.50M
D&A$4.90M$6.00M$6.40M$4.70M$3.40M$2.20M
Operating Income($107.13M)($103.65M)($105.98M)($120.80M)($75.09M)($48.16M)
Interest Expense$5.06M$4.24M$3.31M$4.33M$7.70M$7.25M
Income Tax$0$0$0$0$0$0
Net Income($107.33M)($110.05M)($107.91M)($120.20M)($76.40M)($72.18M)
EPS - Basic($0.59)($0.73)----
EPS - Diluted($0.59)($0.73)----

Balance Sheet

Line itemFY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Cash & Equivalents$135.96M$218.35M$156.72M$226.78M$167.43M$57.39M
Accounts Receivable$41.38M$21.66M$11.77M$16.82M$36.87M$20.33M
Inventory$31.30M$29.62M$46.64M$55.03M$49.46M$19.38M
Accounts Payable$28.30M$9.20M$9.98M$13.74M$10.21M$11.01M
Current Assets$228.35M$283.55M$224.43M$311.86M$277.68M$122.69M
Total Assets$271.40M$321.81M$261.55M$350.02M$294.97M$135.71M
Current Liabilities$96.58M$76.24M$56.91M$59.07M$53.89M$56.19M
Long-term Debt$73.34M$54.03M$56.94M$53.99M$55.36M$44.50M
Total Liabilities$189.16M$152.01M$131.29M$133.84M$127.66M$133.72M
Stockholders' Equity$82.24M$169.79M$130.27M$216.17M$167.31M$1.99M
Retained Earnings($844.46M)($737.13M)($627.08M)($519.18M)($398.98M)($319.85M)

Cash Flow

Line itemFY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Operating Cash Flow($91.71M)($62.09M)($63.47M)($79.57M)($28.16M)($70.05M)
Investing Cash Flow($3.90M)($1.56M)($6.18M)($7.82M)($7.04M)($2.16M)
Financing Cash Flow$18.29M$125.28M($350.0K)$146.21M$28.93M$115.41M
CapEx$3.90M$1.56M$6.18M$7.76M$3.69M$2.16M
Free Cash Flow($95.61M)($63.65M)($69.66M)($87.33M)($31.84M)($72.22M)

Ratios

MetricFY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Profitability
Gross margin9.8%0.5%-7.1%-6.2%29.7%18.6%
Operating margin-104.8%-147.8%-185.9%-137.6%-337.7%-141.5%
EBITDA margin-100.0%-139.3%-174.6%-132.3%-322.4%-135.0%
Net margin-105.0%-156.9%-189.3%-136.9%-343.6%-212.0%
Free cash flow margin-93.5%-90.8%-122.2%-99.5%-143.2%-212.1%
FCF / Net income0.890.580.650.730.421.00
R&D / Revenue31.7%45.4%43.9%27.1%74.3%43.2%
SG&A / Revenue51.3%80.0%108.3%74.9%225.4%92.2%
Effective tax rate------
Return on assets-39.5%-34.2%-41.3%-34.3%-25.9%-53.2%
Return on equity-130.5%-64.8%-82.8%-55.6%-45.7%-3632.4%
Return on invested capital-54.4%-36.6%-44.7%-35.3%-26.6%-81.8%
Liquidity
Current ratio2.363.723.945.285.152.18
Quick ratio2.043.333.124.354.241.84
Cash ratio1.412.862.753.843.111.02
Leverage
Debt / Equity0.890.320.440.250.3322.40
Debt / Assets0.270.170.220.150.190.33
Debt / EBITDA------
Interest coverage-21.2x-24.4x-32.0x-27.9x-9.8x-6.6x
Equity multiplier3.301.902.011.621.7668.30
Liabilities / Assets0.700.470.500.380.430.99
Efficiency
Asset turnover0.380.220.220.250.080.25
Inventory turnover2.942.361.311.690.521.43
Days sales outstanding148d113d75d70d605d218d
Days inventory outstanding124d155d279d215d698d255d
Days payable outstanding112d48d60d54d144d145d
Cash conversion cycle160d220d294d232d1159d328d
Valuation
P / E------
P / B------
P / S------
EV / EBITDA------
Growth
Revenue growth (YoY)45.8%23.0%-35.0%294.8%-34.7%53.1%
Revenue CAGR (3y)5.2%46.6%18.8%58.0%28.9%-
Revenue CAGR (5y)24.6%25.8%40.6%---
Gross profit growth (YoY)2898.5%-25.9%-4.3%-
Operating income growth (YoY)-3.4%2.2%12.3%-60.9%-55.9%-9.0%
Net income growth (YoY)2.5%-2.0%10.2%-57.3%-5.8%-42.5%
EPS growth (YoY)19.2%-----
EPS CAGR (3y)------
EPS CAGR (5y)------
FCF growth (YoY)-50.2%8.6%20.2%-174.3%55.9%-105.2%
FCF CAGR (5y)------
Book value growth (YoY)-51.6%30.3%-39.7%29.2%8320.2%-

Sales by segment

From XBRL dimensional facts in the 10-K period ending 2021-12-31.

Product / service

$70.12M total
Product$51.87M · 74.0%
Service$17.78M · 25.4%
Distribution Service$475.0K · 0.7%

Geographic

$98.07M total
US$42.17M · 43.0%
Non Us$27.95M · 28.5%
Rest Of World$14.04M · 14.3%
FR$7.87M · 8.0%
TW$4.87M · 5.0%
GB$1.17M · 1.2%

Stability scores

Altman Z′

FY 2022 · bankruptcy risk

-2.96
Distress

Private-firm variant - uses book equity instead of market cap. > 2.90 safe · 1.23-2.90 grey · < 1.23 distress.

Piotroski F-score

FY 2022 · 9-point quality

3/9
Weak
  • Net income positive
  • Operating cash flow positive
  • ROA improved YoY
  • Cash flow > net income
  • Long-term debt decreased
  • Current ratio improved
  • No share dilution
  • Gross margin improved
  • Asset turnover improved

Peer comparison

Same SIC group: Electromedical & Electrotherapeutic Apparatus

CompanyRevenue (last FY)Net marginROE
BLFS---1.2%
OM$119.48M-68.3%-64.3%
ITGR$1.85B5.5%5.9%
TMDX$605.49M31.4%40.2%
MDT---

Comparing ViewRay against the 5 most active filers in the same SIC group.